

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-mediated cell contraction (GO:0070252) | 6.39968937 |
| 2 | skeletal muscle fiber development (GO:0048741) | 4.99686419 |
| 3 | regulation of relaxation of muscle (GO:1901077) | 4.92438917 |
| 4 | response to muscle activity (GO:0014850) | 4.85695399 |
| 5 | myofibril assembly (GO:0030239) | 4.81045868 |
| 6 | response to inactivity (GO:0014854) | 4.79740994 |
| 7 | myotube cell development (GO:0014904) | 4.65190433 |
| 8 | creatine metabolic process (GO:0006600) | 4.36280095 |
| 9 | actin filament-based movement (GO:0030048) | 4.35371603 |
| 10 | muscle cell fate commitment (GO:0042693) | 4.18863418 |
| 11 | neuronal action potential propagation (GO:0019227) | 4.08512700 |
| 12 | sarcomere organization (GO:0045214) | 4.04956199 |
| 13 | * muscle contraction (GO:0006936) | 3.92584539 |
| 14 | skeletal muscle tissue development (GO:0007519) | 3.87865553 |
| 15 | cardiac myofibril assembly (GO:0055003) | 3.86931333 |
| 16 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.84722796 |
| 17 | proline transport (GO:0015824) | 3.80509680 |
| 18 | behavioral response to nicotine (GO:0035095) | 3.80118204 |
| 19 | muscle fiber development (GO:0048747) | 3.67417107 |
| 20 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.66091760 |
| 21 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.62481110 |
| 22 | * muscle system process (GO:0003012) | 3.57354083 |
| 23 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.50906659 |
| 24 | cardiac muscle contraction (GO:0060048) | 3.50155104 |
| 25 | regulation of actin filament-based movement (GO:1903115) | 3.49724541 |
| 26 | regulation of skeletal muscle contraction (GO:0014819) | 3.46187318 |
| 27 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.43655404 |
| 28 | plasma membrane repair (GO:0001778) | 3.42585952 |
| 29 | synaptic vesicle maturation (GO:0016188) | 3.40030324 |
| 30 | synaptic transmission, cholinergic (GO:0007271) | 3.39508895 |
| 31 | muscle organ development (GO:0007517) | 3.37312093 |
| 32 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.35622643 |
| 33 | cell communication by electrical coupling (GO:0010644) | 3.35422785 |
| 34 | muscle structure development (GO:0061061) | 3.34046484 |
| 35 | myotube differentiation (GO:0014902) | 3.31379048 |
| 36 | glutamate secretion (GO:0014047) | 3.29394310 |
| 37 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.28824651 |
| 38 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.28792561 |
| 39 | actomyosin structure organization (GO:0031032) | 3.28163710 |
| 40 | vocalization behavior (GO:0071625) | 3.28061030 |
| 41 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.25202157 |
| 42 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.24609705 |
| 43 | cellular potassium ion homeostasis (GO:0030007) | 3.23309428 |
| 44 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.22727802 |
| 45 | glycogen catabolic process (GO:0005980) | 3.22551582 |
| 46 | positive regulation of myotube differentiation (GO:0010831) | 3.18234885 |
| 47 | regulation of striated muscle contraction (GO:0006942) | 3.17444436 |
| 48 | cilium movement (GO:0003341) | 3.17047873 |
| 49 | sodium ion export (GO:0071436) | 3.15624524 |
| 50 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.13522854 |
| 51 | striated muscle adaptation (GO:0014888) | 3.11077471 |
| 52 | striated muscle atrophy (GO:0014891) | 3.10501308 |
| 53 | response to auditory stimulus (GO:0010996) | 3.08200124 |
| 54 | synaptic vesicle exocytosis (GO:0016079) | 3.03709276 |
| 55 | locomotory exploration behavior (GO:0035641) | 3.02173966 |
| 56 | alanine transport (GO:0032328) | 2.98521952 |
| 57 | glucan catabolic process (GO:0009251) | 2.97216611 |
| 58 | regulation of membrane repolarization (GO:0060306) | 2.96474140 |
| 59 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.94700650 |
| 60 | myoblast fusion (GO:0007520) | 2.94097090 |
| 61 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.93812004 |
| 62 | striated muscle cell development (GO:0055002) | 2.88327123 |
| 63 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.87773065 |
| 64 | regulation of beta-amyloid formation (GO:1902003) | 2.87314429 |
| 65 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.87048155 |
| 66 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.87048155 |
| 67 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.86979611 |
| 68 | negative regulation of protein localization to cell surface (GO:2000009) | 2.86840890 |
| 69 | glucan biosynthetic process (GO:0009250) | 2.85438813 |
| 70 | glycogen biosynthetic process (GO:0005978) | 2.85438813 |
| 71 | neurofilament cytoskeleton organization (GO:0060052) | 2.84221586 |
| 72 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.82609907 |
| 73 | neuronal action potential (GO:0019228) | 2.82177806 |
| 74 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.78760727 |
| 75 | skeletal muscle tissue regeneration (GO:0043403) | 2.77782377 |
| 76 | axoneme assembly (GO:0035082) | 2.76959608 |
| 77 | membrane depolarization during action potential (GO:0086010) | 2.76154220 |
| 78 | ubiquinone biosynthetic process (GO:0006744) | 2.75316712 |
| 79 | striated muscle tissue development (GO:0014706) | 2.74402760 |
| 80 | positive regulation of myoblast differentiation (GO:0045663) | 2.73326262 |
| 81 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.73227208 |
| 82 | actin-myosin filament sliding (GO:0033275) | 2.72877107 |
| 83 | muscle filament sliding (GO:0030049) | 2.72877107 |
| 84 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.70883827 |
| 85 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.67636516 |
| 86 | muscle atrophy (GO:0014889) | 2.67261505 |
| 87 | regulation of synapse structural plasticity (GO:0051823) | 2.66179262 |
| 88 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.65340513 |
| 89 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.64488104 |
| 90 | response to gravity (GO:0009629) | 2.64010407 |
| 91 | cellular polysaccharide catabolic process (GO:0044247) | 2.63121425 |
| 92 | cardiac muscle hypertrophy (GO:0003300) | 2.62944763 |
| 93 | regulation of sarcomere organization (GO:0060297) | 2.62897593 |
| 94 | 2-oxoglutarate metabolic process (GO:0006103) | 2.62216799 |
| 95 | potassium ion import (GO:0010107) | 2.62200523 |
| 96 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.61402091 |
| 97 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.61235862 |
| 98 | neurotransmitter catabolic process (GO:0042135) | 2.61025167 |
| 99 | regulation of cell communication by electrical coupling (GO:0010649) | 2.60175164 |
| 100 | regulation of synaptic vesicle transport (GO:1902803) | 2.59985597 |
| 101 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.59933368 |
| 102 | heart process (GO:0003015) | 2.58714366 |
| 103 | heart contraction (GO:0060047) | 2.58714366 |
| 104 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.57933477 |
| 105 | positive regulation of synapse maturation (GO:0090129) | 2.55905023 |
| 106 | cell communication involved in cardiac conduction (GO:0086065) | 2.55444563 |
| 107 | regulation of sequestering of triglyceride (GO:0010889) | 2.55154989 |
| 108 | response to activity (GO:0014823) | 2.55114958 |
| 109 | skeletal muscle contraction (GO:0003009) | 2.54801042 |
| 110 | neuromuscular synaptic transmission (GO:0007274) | 2.53960494 |
| 111 | postsynaptic membrane organization (GO:0001941) | 2.53770483 |
| 112 | negative regulation of sodium ion transport (GO:0010766) | 2.53273147 |
| 113 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.53023617 |
| 114 | striated muscle hypertrophy (GO:0014897) | 2.52935551 |
| 115 | muscle cell cellular homeostasis (GO:0046716) | 2.52482830 |
| 116 | neurotransmitter secretion (GO:0007269) | 2.52398660 |
| 117 | regulation of synapse maturation (GO:0090128) | 2.51355115 |
| 118 | relaxation of muscle (GO:0090075) | 2.50412583 |
| 119 | polysaccharide catabolic process (GO:0000272) | 2.49083536 |
| 120 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.48312135 |
| 121 | positive regulation of potassium ion transport (GO:0043268) | 2.47593072 |
| 122 | carnitine shuttle (GO:0006853) | 2.47039679 |
| 123 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.47013877 |
| 124 | muscle cell development (GO:0055001) | 2.46428052 |
| 125 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.46398134 |
| 126 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.46398134 |
| 127 | cellular sodium ion homeostasis (GO:0006883) | 2.46285075 |
| 128 | negative regulation of hormone metabolic process (GO:0032351) | 2.45843893 |
| 129 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.45843893 |
| 130 | tricarboxylic acid cycle (GO:0006099) | 2.45436262 |
| 131 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.45426645 |
| 132 | ubiquinone metabolic process (GO:0006743) | 2.45266367 |
| 133 | regulation of muscle system process (GO:0090257) | 2.43847963 |
| 134 | protein localization to synapse (GO:0035418) | 2.43476788 |
| 135 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.43336774 |
| 136 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.42073740 |
| 137 | innervation (GO:0060384) | 2.41917156 |
| 138 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.40353989 |
| 139 | muscle tissue development (GO:0060537) | 2.40132627 |
| 140 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.40015877 |
| 141 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.38706998 |
| 142 | neuron cell-cell adhesion (GO:0007158) | 2.38288674 |
| 143 | auditory receptor cell stereocilium organization (GO:0060088) | 2.38242966 |
| 144 | long-term synaptic potentiation (GO:0060291) | 2.38124134 |
| 145 | auditory behavior (GO:0031223) | 2.37906829 |
| 146 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.37177476 |
| 147 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.36830026 |
| 148 | striated muscle contraction (GO:0006941) | 2.35667705 |
| 149 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.33417754 |
| 150 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.33015536 |
| 151 | layer formation in cerebral cortex (GO:0021819) | 2.32939361 |
| 152 | neuromuscular process controlling posture (GO:0050884) | 2.32291619 |
| 153 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.31589761 |
| 154 | activation of protein kinase A activity (GO:0034199) | 2.29516018 |
| 155 | neuromuscular junction development (GO:0007528) | 2.29321100 |
| 156 | membrane repolarization (GO:0086009) | 2.28936675 |
| 157 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.28761515 |
| 158 | striatum development (GO:0021756) | 2.27948511 |
| 159 | glial cell proliferation (GO:0014009) | 2.25912924 |
| 160 | chondroitin sulfate catabolic process (GO:0030207) | 2.25080737 |
| 161 | skeletal muscle adaptation (GO:0043501) | 2.24978830 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.80368685 |
| 2 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.69684762 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.62826223 |
| 4 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.48821715 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.43171414 |
| 6 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.40471234 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.39535416 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.39535416 |
| 9 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.38698952 |
| 10 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.36113002 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.30840403 |
| 12 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.30367179 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.29265395 |
| 14 | VDR_22108803_ChIP-Seq_LS180_Human | 2.27771325 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.27396224 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.22612979 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.18096313 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.00797179 |
| 19 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.00381346 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.00199901 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.91698344 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.90645794 |
| 23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.88917348 |
| 24 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.68373123 |
| 25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.68366843 |
| 26 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.64386132 |
| 27 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.59583389 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.49452795 |
| 29 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.48737958 |
| 30 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.48708989 |
| 31 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.46756972 |
| 32 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.45298408 |
| 33 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.43553622 |
| 34 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.42516317 |
| 35 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.42177586 |
| 36 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.42057431 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41617682 |
| 38 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.41195958 |
| 39 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.38978837 |
| 40 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.38343846 |
| 41 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.36369177 |
| 42 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.35309406 |
| 43 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.31143019 |
| 44 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.30869564 |
| 45 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.29968921 |
| 46 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.29691369 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.29209133 |
| 48 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.28919980 |
| 49 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.27912837 |
| 50 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.27008547 |
| 51 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.26361056 |
| 52 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.24105119 |
| 53 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.22882544 |
| 54 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21704071 |
| 55 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.19944131 |
| 56 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.19677826 |
| 57 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.19473252 |
| 58 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19401225 |
| 59 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.19244159 |
| 60 | AR_25329375_ChIP-Seq_VCAP_Human | 1.17179003 |
| 61 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.16621575 |
| 62 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.16394978 |
| 63 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.15621797 |
| 64 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.14761866 |
| 65 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14668461 |
| 66 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.13803708 |
| 67 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.12202953 |
| 68 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.08682129 |
| 69 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08203967 |
| 70 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.08001495 |
| 71 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.07691932 |
| 72 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.07565074 |
| 73 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.07174410 |
| 74 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.07027013 |
| 75 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06241075 |
| 76 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.05530608 |
| 77 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.05241072 |
| 78 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.05241072 |
| 79 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04448378 |
| 80 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.04166175 |
| 81 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.02843016 |
| 82 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.00866986 |
| 83 | P300_19829295_ChIP-Seq_ESCs_Human | 1.00463177 |
| 84 | AR_19668381_ChIP-Seq_PC3_Human | 0.98740777 |
| 85 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.98315513 |
| 86 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98312115 |
| 87 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97811642 |
| 88 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.97406981 |
| 89 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.96666564 |
| 90 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.96523168 |
| 91 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.95103683 |
| 92 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.94734476 |
| 93 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.94560077 |
| 94 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.93250780 |
| 95 | KDM2B_26808549_Chip-Seq_K562_Human | 0.92270477 |
| 96 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.91799557 |
| 97 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.91799557 |
| 98 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91619360 |
| 99 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90676815 |
| 100 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.90514159 |
| 101 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.90514159 |
| 102 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90065340 |
| 103 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89805458 |
| 104 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.89649440 |
| 105 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.88132117 |
| 106 | TP53_16413492_ChIP-PET_HCT116_Human | 0.88036249 |
| 107 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.87862523 |
| 108 | STAT3_23295773_ChIP-Seq_U87_Human | 0.87515762 |
| 109 | FUS_26573619_Chip-Seq_HEK293_Human | 0.87074279 |
| 110 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.86936424 |
| 111 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.86692690 |
| 112 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.86692690 |
| 113 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.86618629 |
| 114 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.86236857 |
| 115 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86140507 |
| 116 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.86101602 |
| 117 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.86008340 |
| 118 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.85961040 |
| 119 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.84059823 |
| 120 | TCF4_23295773_ChIP-Seq_U87_Human | 0.83878676 |
| 121 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.83324804 |
| 122 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83106380 |
| 123 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.82958996 |
| 124 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.82376958 |
| 125 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.82145014 |
| 126 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.81994510 |
| 127 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.81974545 |
| 128 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.81842127 |
| 129 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81450048 |
| 130 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.81066884 |
| 131 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.80870713 |
| 132 | CJUN_26792858_Chip-Seq_BT549_Human | 0.80311203 |
| 133 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.79393554 |
| 134 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.79304628 |
| 135 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.78870714 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 3.72563333 |
| 2 | MP0000751_myopathy | 3.69225259 |
| 3 | MP0004145_abnormal_muscle_electrophysio | 3.39353036 |
| 4 | MP0000749_muscle_degeneration | 3.11502226 |
| 5 | MP0003646_muscle_fatigue | 2.91608863 |
| 6 | MP0004270_analgesia | 2.88852553 |
| 7 | MP0004858_abnormal_nervous_system | 2.79802670 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 2.44950062 |
| 9 | MP0003635_abnormal_synaptic_transmissio | 2.34638255 |
| 10 | MP0003950_abnormal_plasma_membrane | 2.26737380 |
| 11 | MP0004130_abnormal_muscle_cell | 2.24838835 |
| 12 | MP0004036_abnormal_muscle_relaxation | 2.19273705 |
| 13 | MP0009780_abnormal_chondrocyte_physiolo | 2.10210338 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.10115060 |
| 15 | MP0003880_abnormal_central_pattern | 2.05850560 |
| 16 | MP0009046_muscle_twitch | 2.02267967 |
| 17 | MP0005646_abnormal_pituitary_gland | 2.02083453 |
| 18 | MP0005423_abnormal_somatic_nervous | 2.01975357 |
| 19 | MP0002254_reproductive_system_inflammat | 2.00022909 |
| 20 | MP0000733_abnormal_muscle_development | 1.99813193 |
| 21 | MP0002909_abnormal_adrenal_gland | 1.98298210 |
| 22 | MP0001986_abnormal_taste_sensitivity | 1.97612339 |
| 23 | MP0000747_muscle_weakness | 1.91521304 |
| 24 | MP0003329_amyloid_beta_deposits | 1.89794510 |
| 25 | MP0002735_abnormal_chemical_nociception | 1.89249275 |
| 26 | MP0002734_abnormal_mechanical_nocicepti | 1.87190458 |
| 27 | MP0009745_abnormal_behavioral_response | 1.85928830 |
| 28 | MP0002064_seizures | 1.84121873 |
| 29 | MP0002736_abnormal_nociception_after | 1.82820808 |
| 30 | MP0002063_abnormal_learning/memory/cond | 1.74253192 |
| 31 | MP0008569_lethality_at_weaning | 1.62854691 |
| 32 | MP0001501_abnormal_sleep_pattern | 1.61303099 |
| 33 | MP0005330_cardiomyopathy | 1.60943515 |
| 34 | MP0005620_abnormal_muscle_contractility | 1.60431214 |
| 35 | MP0002733_abnormal_thermal_nociception | 1.58086108 |
| 36 | MP0002106_abnormal_muscle_physiology | 1.58002687 |
| 37 | MP0000759_abnormal_skeletal_muscle | 1.55788214 |
| 38 | MP0002272_abnormal_nervous_system | 1.54890512 |
| 39 | MP0000750_abnormal_muscle_regeneration | 1.54207530 |
| 40 | MP0000013_abnormal_adipose_tissue | 1.52478328 |
| 41 | MP0002572_abnormal_emotion/affect_behav | 1.52136393 |
| 42 | MP0001486_abnormal_startle_reflex | 1.50618627 |
| 43 | MP0001440_abnormal_grooming_behavior | 1.47845265 |
| 44 | MP0006036_abnormal_mitochondrial_physio | 1.46865272 |
| 45 | MP0005623_abnormal_meninges_morphology | 1.46189464 |
| 46 | MP0002067_abnormal_sensory_capabilities | 1.46038306 |
| 47 | MP0002269_muscular_atrophy | 1.43628438 |
| 48 | MP0005369_muscle_phenotype | 1.40379409 |
| 49 | MP0003690_abnormal_glial_cell | 1.34718995 |
| 50 | MP0001970_abnormal_pain_threshold | 1.34596022 |
| 51 | MP0004087_abnormal_muscle_fiber | 1.34002469 |
| 52 | MP0003136_yellow_coat_color | 1.31517783 |
| 53 | MP0004215_abnormal_myocardial_fiber | 1.30541596 |
| 54 | MP0004233_abnormal_muscle_weight | 1.24449624 |
| 55 | MP0002557_abnormal_social/conspecific_i | 1.23917741 |
| 56 | MP0002184_abnormal_innervation | 1.21432665 |
| 57 | MP0006276_abnormal_autonomic_nervous | 1.18838780 |
| 58 | MP0003011_delayed_dark_adaptation | 1.17915665 |
| 59 | MP0001984_abnormal_olfaction | 1.16906078 |
| 60 | MP0001502_abnormal_circadian_rhythm | 1.12991329 |
| 61 | MP0000372_irregular_coat_pigmentation | 1.12026809 |
| 62 | MP0003634_abnormal_glial_cell | 1.11107918 |
| 63 | MP0002876_abnormal_thyroid_physiology | 1.10315073 |
| 64 | MP0000778_abnormal_nervous_system | 1.10278973 |
| 65 | MP0002972_abnormal_cardiac_muscle | 1.09250084 |
| 66 | MP0000955_abnormal_spinal_cord | 1.05908202 |
| 67 | MP0002108_abnormal_muscle_morphology | 1.05612081 |
| 68 | MP0004084_abnormal_cardiac_muscle | 1.04929521 |
| 69 | MP0004484_altered_response_of | 1.03273219 |
| 70 | MP0009384_cardiac_valve_regurgitation | 1.02331312 |
| 71 | MP0004811_abnormal_neuron_physiology | 1.02116891 |
| 72 | MP0003633_abnormal_nervous_system | 1.01401134 |
| 73 | MP0005670_abnormal_white_adipose | 1.00106623 |
| 74 | MP0003137_abnormal_impulse_conducting | 0.98331505 |
| 75 | MP0002971_abnormal_brown_adipose | 0.98252734 |
| 76 | MP0003279_aneurysm | 0.95717324 |
| 77 | MP0000604_amyloidosis | 0.94137786 |
| 78 | MP0001348_abnormal_lacrimal_gland | 0.93912650 |
| 79 | MP0002882_abnormal_neuron_morphology | 0.93659513 |
| 80 | MP0005551_abnormal_eye_electrophysiolog | 0.93573848 |
| 81 | MP0005171_absent_coat_pigmentation | 0.93455310 |
| 82 | MP0005385_cardiovascular_system_phenoty | 0.92538641 |
| 83 | MP0002066_abnormal_motor_capabilities/c | 0.92504645 |
| 84 | MP0004924_abnormal_behavior | 0.92371255 |
| 85 | MP0005386_behavior/neurological_phenoty | 0.92371255 |
| 86 | MP0002332_abnormal_exercise_endurance | 0.90254481 |
| 87 | MP0005266_abnormal_metabolism | 0.90108455 |
| 88 | MP0005451_abnormal_body_composition | 0.89856308 |
| 89 | MP0003075_altered_response_to | 0.88893068 |
| 90 | MP0004085_abnormal_heartbeat | 0.87259238 |
| 91 | MP0004142_abnormal_muscle_tone | 0.86260357 |
| 92 | MP0008775_abnormal_heart_ventricle | 0.84816320 |
| 93 | MP0004043_abnormal_pH_regulation | 0.84180594 |
| 94 | MP0010030_abnormal_orbit_morphology | 0.83997643 |
| 95 | MP0002822_catalepsy | 0.83074584 |
| 96 | MP0001346_abnormal_lacrimal_gland | 0.82873405 |
| 97 | MP0001270_distended_abdomen | 0.80480034 |
| 98 | MP0003959_abnormal_lean_body | 0.80036356 |
| 99 | MP0002127_abnormal_cardiovascular_syste | 0.79064451 |
| 100 | MP0002653_abnormal_ependyma_morphology | 0.79024864 |
| 101 | MP0002234_abnormal_pharynx_morphology | 0.78904293 |
| 102 | MP0001661_extended_life_span | 0.78663733 |
| 103 | MP0003879_abnormal_hair_cell | 0.77725240 |
| 104 | MP0001958_emphysema | 0.76674165 |
| 105 | MP0001299_abnormal_eye_distance/ | 0.76672513 |
| 106 | MP0006138_congestive_heart_failure | 0.74813223 |
| 107 | MP0002638_abnormal_pupillary_reflex | 0.73897797 |
| 108 | MP0000681_abnormal_thyroid_gland | 0.73761032 |
| 109 | MP0005253_abnormal_eye_physiology | 0.69920488 |
| 110 | MP0005666_abnormal_adipose_tissue | 0.69656653 |
| 111 | MP0004147_increased_porphyrin_level | 0.69569100 |
| 112 | MP0003631_nervous_system_phenotype | 0.69386225 |
| 113 | MP0002089_abnormal_postnatal_growth/wei | 0.69379008 |
| 114 | MP0008875_abnormal_xenobiotic_pharmacok | 0.69317986 |
| 115 | MP0010386_abnormal_urinary_bladder | 0.67379715 |
| 116 | MP0008438_abnormal_cutaneous_collagen | 0.66899370 |
| 117 | MP0004885_abnormal_endolymph | 0.66803422 |
| 118 | MP0001664_abnormal_digestion | 0.66290400 |
| 119 | MP0003183_abnormal_peptide_metabolism | 0.66267699 |
| 120 | MP0000003_abnormal_adipose_tissue | 0.66208006 |
| 121 | MP0005165_increased_susceptibility_to | 0.65450361 |
| 122 | MP0005535_abnormal_body_temperature | 0.65400246 |
| 123 | MP0003705_abnormal_hypodermis_morpholog | 0.65215547 |
| 124 | MP0006072_abnormal_retinal_apoptosis | 0.64962574 |
| 125 | MP0008877_abnormal_DNA_methylation | 0.64081080 |
| 126 | MP0001544_abnormal_cardiovascular_syste | 0.64004527 |
| 127 | MP0008872_abnormal_physiological_respon | 0.62153122 |
| 128 | MP0010630_abnormal_cardiac_muscle | 0.62136212 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 5.33970280 |
| 2 | Abnormal ciliary motility (HP:0012262) | 4.57276810 |
| 3 | Popliteal pterygium (HP:0009756) | 4.20125284 |
| 4 | Type 2 muscle fiber atrophy (HP:0003554) | 4.02186996 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.98602219 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 3.98013612 |
| 7 | Distal arthrogryposis (HP:0005684) | 3.93104235 |
| 8 | Myokymia (HP:0002411) | 3.88867936 |
| 9 | Muscle fiber inclusion bodies (HP:0100299) | 3.84271861 |
| 10 | Difficulty running (HP:0009046) | 3.80859711 |
| 11 | Malignant hyperthermia (HP:0002047) | 3.78619457 |
| 12 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.74853013 |
| 13 | Calf muscle hypertrophy (HP:0008981) | 3.71875280 |
| 14 | Calcaneovalgus deformity (HP:0001848) | 3.71497695 |
| 15 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.66946722 |
| 16 | Weak cry (HP:0001612) | 3.56998906 |
| 17 | Focal motor seizures (HP:0011153) | 3.51105519 |
| 18 | Muscle fiber atrophy (HP:0100295) | 3.49973658 |
| 19 | Type 1 muscle fiber predominance (HP:0003803) | 3.44218419 |
| 20 | Myoglobinuria (HP:0002913) | 3.39197071 |
| 21 | Megalencephaly (HP:0001355) | 3.37945796 |
| 22 | Hyporeflexia of lower limbs (HP:0002600) | 3.29039022 |
| 23 | Deformed tarsal bones (HP:0008119) | 3.27852263 |
| 24 | Nemaline bodies (HP:0003798) | 3.20819744 |
| 25 | Myotonia (HP:0002486) | 3.20069221 |
| 26 | Muscle stiffness (HP:0003552) | 3.11178912 |
| 27 | Abnormality of the calf musculature (HP:0001430) | 2.97824607 |
| 28 | Increased variability in muscle fiber diameter (HP:0003557) | 2.96074269 |
| 29 | Abnormality of placental membranes (HP:0011409) | 2.84764187 |
| 30 | Amniotic constriction ring (HP:0009775) | 2.84764187 |
| 31 | Back pain (HP:0003418) | 2.81452591 |
| 32 | Round ear (HP:0100830) | 2.78027428 |
| 33 | Nonprogressive disorder (HP:0003680) | 2.75057540 |
| 34 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.72284789 |
| 35 | Generalized muscle weakness (HP:0003324) | 2.70958542 |
| 36 | Rhinitis (HP:0012384) | 2.64139815 |
| 37 | Visual hallucinations (HP:0002367) | 2.63341282 |
| 38 | Muscle fiber splitting (HP:0003555) | 2.60794992 |
| 39 | Broad metatarsal (HP:0001783) | 2.58718474 |
| 40 | Myopathic facies (HP:0002058) | 2.55268300 |
| 41 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.53160453 |
| 42 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.53160453 |
| 43 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.52864110 |
| 44 | Bulbar palsy (HP:0001283) | 2.52420068 |
| 45 | Akinesia (HP:0002304) | 2.51991797 |
| 46 | Action tremor (HP:0002345) | 2.50648294 |
| 47 | Asymmetric septal hypertrophy (HP:0001670) | 2.47167803 |
| 48 | Ulnar deviation of the wrist (HP:0003049) | 2.44186478 |
| 49 | Hip contracture (HP:0003273) | 2.43708966 |
| 50 | EMG: neuropathic changes (HP:0003445) | 2.37498016 |
| 51 | EMG: myopathic abnormalities (HP:0003458) | 2.35104195 |
| 52 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.34979610 |
| 53 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.33538116 |
| 54 | Aplasia of the phalanges of the hand (HP:0009802) | 2.33538116 |
| 55 | Aplasia involving bones of the extremities (HP:0009825) | 2.33538116 |
| 56 | Easy fatigability (HP:0003388) | 2.33023187 |
| 57 | Limb-girdle muscle atrophy (HP:0003797) | 2.32453314 |
| 58 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.30937971 |
| 59 | Increased connective tissue (HP:0009025) | 2.27063533 |
| 60 | Focal seizures (HP:0007359) | 2.26571116 |
| 61 | Hyperkalemia (HP:0002153) | 2.25943659 |
| 62 | Supranuclear gaze palsy (HP:0000605) | 2.24005751 |
| 63 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.22416193 |
| 64 | Subaortic stenosis (HP:0001682) | 2.22416193 |
| 65 | Aplasia of the musculature (HP:0100854) | 2.19738385 |
| 66 | Sudden death (HP:0001699) | 2.19410759 |
| 67 | Epileptic encephalopathy (HP:0200134) | 2.18578851 |
| 68 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 2.16939205 |
| 69 | Areflexia of lower limbs (HP:0002522) | 2.16878852 |
| 70 | Type II lissencephaly (HP:0007260) | 2.15780550 |
| 71 | Absent/shortened dynein arms (HP:0200106) | 2.08881528 |
| 72 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.08881528 |
| 73 | Atonic seizures (HP:0010819) | 2.07205189 |
| 74 | Ulnar claw (HP:0001178) | 2.04082782 |
| 75 | Rhabdomyolysis (HP:0003201) | 2.03255061 |
| 76 | Difficulty climbing stairs (HP:0003551) | 2.00158892 |
| 77 | Progressive cerebellar ataxia (HP:0002073) | 1.98158857 |
| 78 | Scapular winging (HP:0003691) | 1.95577324 |
| 79 | Thin ribs (HP:0000883) | 1.93881051 |
| 80 | Hypothermia (HP:0002045) | 1.93017883 |
| 81 | Facial diplegia (HP:0001349) | 1.92625974 |
| 82 | Bundle branch block (HP:0011710) | 1.91675746 |
| 83 | Neurofibrillary tangles (HP:0002185) | 1.88533524 |
| 84 | Generalized tonic-clonic seizures (HP:0002069) | 1.84657081 |
| 85 | Hemiplegia (HP:0002301) | 1.84126567 |
| 86 | Absent phalangeal crease (HP:0006109) | 1.83563793 |
| 87 | Anxiety (HP:0000739) | 1.82004506 |
| 88 | Narrow nasal bridge (HP:0000446) | 1.81310731 |
| 89 | Fetal akinesia sequence (HP:0001989) | 1.81169133 |
| 90 | Limited hip movement (HP:0008800) | 1.80486695 |
| 91 | Waddling gait (HP:0002515) | 1.79704651 |
| 92 | Stridor (HP:0010307) | 1.79348499 |
| 93 | Left ventricular hypertrophy (HP:0001712) | 1.79319894 |
| 94 | Lipoatrophy (HP:0100578) | 1.78874491 |
| 95 | Ankle clonus (HP:0011448) | 1.78630266 |
| 96 | Febrile seizures (HP:0002373) | 1.78210154 |
| 97 | Oligomenorrhea (HP:0000876) | 1.78194514 |
| 98 | Gowers sign (HP:0003391) | 1.77825932 |
| 99 | Abnormality of the calcaneus (HP:0008364) | 1.77596218 |
| 100 | Long clavicles (HP:0000890) | 1.75368601 |
| 101 | Dilated cardiomyopathy (HP:0001644) | 1.74702435 |
| 102 | Proximal amyotrophy (HP:0007126) | 1.74109298 |
| 103 | Abnormal finger flexion creases (HP:0006143) | 1.73934212 |
| 104 | Truncal ataxia (HP:0002078) | 1.73905436 |
| 105 | Median cleft lip (HP:0000161) | 1.71153114 |
| 106 | Neonatal respiratory distress (HP:0002643) | 1.70114678 |
| 107 | Pterygium (HP:0001059) | 1.69609080 |
| 108 | Gait imbalance (HP:0002141) | 1.69581266 |
| 109 | Hypoplastic ischia (HP:0003175) | 1.69090817 |
| 110 | Cerebral inclusion bodies (HP:0100314) | 1.69039519 |
| 111 | Prolonged QT interval (HP:0001657) | 1.67803756 |
| 112 | Abnormal atrioventricular conduction (HP:0005150) | 1.67376338 |
| 113 | Frequent falls (HP:0002359) | 1.64679112 |
| 114 | Methylmalonic acidemia (HP:0002912) | 1.64586309 |
| 115 | Delayed gross motor development (HP:0002194) | 1.64523988 |
| 116 | Lower limb muscle weakness (HP:0007340) | 1.63824662 |
| 117 | Heart block (HP:0012722) | 1.63486909 |
| 118 | Spinal rigidity (HP:0003306) | 1.62374990 |
| 119 | Neck muscle weakness (HP:0000467) | 1.62153647 |
| 120 | Fatigable weakness (HP:0003473) | 1.62145798 |
| 121 | Abnormality of the neuromuscular junction (HP:0003398) | 1.62145798 |
| 122 | Depression (HP:0000716) | 1.61923847 |
| 123 | Congenital primary aphakia (HP:0007707) | 1.61599346 |
| 124 | Torticollis (HP:0000473) | 1.61558777 |
| 125 | Ventricular fibrillation (HP:0001663) | 1.61031220 |
| 126 | Rimmed vacuoles (HP:0003805) | 1.60180666 |
| 127 | Shoulder girdle muscle weakness (HP:0003547) | 1.60115064 |
| 128 | Hypoplastic left heart (HP:0004383) | 1.59963101 |
| 129 | Impaired pain sensation (HP:0007328) | 1.59796825 |
| 130 | Abnormality of pain sensation (HP:0010832) | 1.59796825 |
| 131 | Lower limb amyotrophy (HP:0007210) | 1.59761047 |
| 132 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.59411875 |
| 133 | Abnormal eating behavior (HP:0100738) | 1.58788026 |
| 134 | Hemiparesis (HP:0001269) | 1.58619507 |
| 135 | Pheochromocytoma (HP:0002666) | 1.58382021 |
| 136 | Distal lower limb muscle weakness (HP:0009053) | 1.58303051 |
| 137 | Muscular dystrophy (HP:0003560) | 1.57978220 |
| 138 | Depressed nasal tip (HP:0000437) | 1.57247658 |
| 139 | Progressive inability to walk (HP:0002505) | 1.57086641 |
| 140 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.56334958 |
| 141 | Slender build (HP:0001533) | 1.56115004 |
| 142 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.55358134 |
| 143 | Large for gestational age (HP:0001520) | 1.54957624 |
| 144 | Anterior segment dysgenesis (HP:0007700) | 1.54602483 |
| 145 | Limb-girdle muscle weakness (HP:0003325) | 1.53882970 |
| 146 | Abnormality of the ischium (HP:0003174) | 1.50693304 |
| 147 | Ventricular arrhythmia (HP:0004308) | 1.49094084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LMTK2 | 5.56567845 |
| 2 | PHKG2 | 4.47480213 |
| 3 | PHKG1 | 4.47480213 |
| 4 | CASK | 2.95795377 |
| 5 | NTRK3 | 2.50083571 |
| 6 | TTN | 2.28402349 |
| 7 | MAPK15 | 1.96596853 |
| 8 | NTRK2 | 1.94049410 |
| 9 | MAP2K4 | 1.90832474 |
| 10 | EPHA4 | 1.90110796 |
| 11 | OBSCN | 1.87051848 |
| 12 | MINK1 | 1.84980691 |
| 13 | MUSK | 1.83372936 |
| 14 | SIK1 | 1.72390085 |
| 15 | TRIB3 | 1.71953320 |
| 16 | PDK4 | 1.70762760 |
| 17 | PDK3 | 1.70762760 |
| 18 | MAP3K9 | 1.70269187 |
| 19 | MAP3K12 | 1.65674682 |
| 20 | MAPKAPK3 | 1.62177557 |
| 21 | PRKD3 | 1.56698110 |
| 22 | MOS | 1.56420236 |
| 23 | PINK1 | 1.52892624 |
| 24 | INSRR | 1.49058293 |
| 25 | MAP3K4 | 1.48680990 |
| 26 | CAMKK2 | 1.44374898 |
| 27 | PNCK | 1.42161583 |
| 28 | CCNB1 | 1.37543667 |
| 29 | MAP2K7 | 1.35655075 |
| 30 | BCKDK | 1.32097994 |
| 31 | WNK4 | 1.29498937 |
| 32 | SGK2 | 1.26203567 |
| 33 | MAP3K2 | 1.22942523 |
| 34 | DAPK2 | 1.22275423 |
| 35 | MARK1 | 1.22095851 |
| 36 | GRK1 | 1.18618290 |
| 37 | DMPK | 1.17061083 |
| 38 | CAMKK1 | 1.16541527 |
| 39 | MAP3K7 | 1.12696881 |
| 40 | SGK494 | 1.09024783 |
| 41 | SGK223 | 1.09024783 |
| 42 | KSR2 | 1.08526307 |
| 43 | SGK3 | 1.08173741 |
| 44 | PAK3 | 1.03641778 |
| 45 | FER | 1.02363317 |
| 46 | PAK6 | 1.01570699 |
| 47 | SIK2 | 0.98800722 |
| 48 | NTRK1 | 0.98583714 |
| 49 | PTK2B | 0.97581592 |
| 50 | MAPK13 | 0.96290312 |
| 51 | PIK3CG | 0.95296981 |
| 52 | FRK | 0.94373427 |
| 53 | PDK2 | 0.93130893 |
| 54 | RET | 0.92079580 |
| 55 | CDK19 | 0.91174903 |
| 56 | LATS2 | 0.86199765 |
| 57 | LIMK1 | 0.82920172 |
| 58 | CDK5 | 0.82229749 |
| 59 | CAMK2B | 0.81799675 |
| 60 | TRPM7 | 0.81673083 |
| 61 | MAPKAPK5 | 0.78808427 |
| 62 | NME1 | 0.78201929 |
| 63 | PRKCH | 0.78113427 |
| 64 | MAPK12 | 0.73934408 |
| 65 | PKN1 | 0.73649624 |
| 66 | NEK1 | 0.73143406 |
| 67 | MAP3K13 | 0.71420965 |
| 68 | MAP2K1 | 0.70677358 |
| 69 | ROCK2 | 0.70084708 |
| 70 | RPS6KA2 | 0.69731581 |
| 71 | ROCK1 | 0.68235726 |
| 72 | ADRBK2 | 0.67436502 |
| 73 | PIK3CA | 0.65391750 |
| 74 | MYLK | 0.64639541 |
| 75 | PRKCG | 0.64253992 |
| 76 | MARK2 | 0.63063871 |
| 77 | OXSR1 | 0.62181217 |
| 78 | MAP2K3 | 0.62080324 |
| 79 | ADRBK1 | 0.61197187 |
| 80 | MAP2K6 | 0.60588438 |
| 81 | STK39 | 0.60219424 |
| 82 | AKT2 | 0.59925408 |
| 83 | GRK5 | 0.57698796 |
| 84 | CAMK2A | 0.57429781 |
| 85 | CAMK1 | 0.56652520 |
| 86 | PRKG1 | 0.54939127 |
| 87 | STK11 | 0.50171127 |
| 88 | MET | 0.50157213 |
| 89 | DYRK1B | 0.49771150 |
| 90 | CAMK2G | 0.49652719 |
| 91 | ARAF | 0.48009325 |
| 92 | PDPK1 | 0.47475481 |
| 93 | MAPK11 | 0.47283714 |
| 94 | PDK1 | 0.46370118 |
| 95 | FGR | 0.46198397 |
| 96 | UHMK1 | 0.46080633 |
| 97 | PRKCE | 0.45855501 |
| 98 | CAMK2D | 0.45592254 |
| 99 | EPHB1 | 0.45591045 |
| 100 | SGK1 | 0.45367263 |
| 101 | DDR2 | 0.45245780 |
| 102 | CAMK1G | 0.44454530 |
| 103 | PAK2 | 0.44248624 |
| 104 | MAP3K1 | 0.42955754 |
| 105 | PRPF4B | 0.42125966 |
| 106 | ERBB3 | 0.42080770 |
| 107 | STK38 | 0.41862133 |
| 108 | MAP2K2 | 0.40623061 |
| 109 | PDGFRA | 0.39761396 |
| 110 | CAMK4 | 0.39605272 |
| 111 | PRKACB | 0.38791876 |
| 112 | SIK3 | 0.38096554 |
| 113 | PTK2 | 0.37322982 |
| 114 | WNK1 | 0.37308833 |
| 115 | TYRO3 | 0.36876538 |
| 116 | MAPK7 | 0.36599339 |
| 117 | MAPK4 | 0.36467960 |
| 118 | RPS6KA3 | 0.35738248 |
| 119 | MAP4K2 | 0.35226525 |
| 120 | TNIK | 0.35082657 |
| 121 | LRRK2 | 0.34759398 |
| 122 | PLK2 | 0.34346197 |
| 123 | CDC42BPA | 0.34150785 |
| 124 | PKN2 | 0.34028427 |
| 125 | NEK9 | 0.33666675 |
| 126 | PRKAA1 | 0.31331643 |
| 127 | KSR1 | 0.30971615 |
| 128 | PRKACA | 0.30945690 |
| 129 | PRKAA2 | 0.30887768 |
| 130 | ILK | 0.30528889 |
| 131 | PRKCA | 0.28831854 |
| 132 | CDK11A | 0.24977247 |
| 133 | WNK3 | 0.24940869 |
| 134 | BMPR1B | 0.24469001 |
| 135 | FLT3 | 0.23706414 |
| 136 | CDK15 | 0.23167003 |
| 137 | CDK8 | 0.21382909 |
| 138 | PRKACG | 0.20520291 |
| 139 | CSNK1G2 | 0.20332836 |
| 140 | CSNK1D | 0.20297471 |
| 141 | CDK18 | 0.17478219 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.23749853 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.18228410 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.05118100 |
| 4 | Phototransduction_Homo sapiens_hsa04744 | 1.96067572 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.88299748 |
| 6 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.76176787 |
| 7 | Nicotine addiction_Homo sapiens_hsa05033 | 1.74718051 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 1.73993178 |
| 9 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.73297306 |
| 10 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.72134085 |
| 11 | Circadian entrainment_Homo sapiens_hsa04713 | 1.71333649 |
| 12 | Circadian rhythm_Homo sapiens_hsa04710 | 1.64661503 |
| 13 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.63181707 |
| 14 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.60867326 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.57957086 |
| 16 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.57519370 |
| 17 | GABAergic synapse_Homo sapiens_hsa04727 | 1.56650776 |
| 18 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.52937037 |
| 19 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.47788085 |
| 20 | Salivary secretion_Homo sapiens_hsa04970 | 1.47666662 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.47013089 |
| 22 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.45977870 |
| 23 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.41611903 |
| 24 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.41271969 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.40621557 |
| 26 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.38380308 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.38296893 |
| 28 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.38207032 |
| 29 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.37506706 |
| 30 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.36669959 |
| 31 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.35000070 |
| 32 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.33956221 |
| 33 | Long-term potentiation_Homo sapiens_hsa04720 | 1.32767620 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.31423973 |
| 35 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.29557514 |
| 36 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.23730677 |
| 37 | Taste transduction_Homo sapiens_hsa04742 | 1.22070063 |
| 38 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.21432174 |
| 39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.18881999 |
| 40 | Morphine addiction_Homo sapiens_hsa05032 | 1.17256781 |
| 41 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.14738386 |
| 42 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.12730053 |
| 43 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.10093333 |
| 44 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.07982653 |
| 45 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.07120631 |
| 46 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.06055983 |
| 47 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.05407609 |
| 48 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.02828357 |
| 49 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.01760847 |
| 50 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.00816328 |
| 51 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.00688734 |
| 52 | Cocaine addiction_Homo sapiens_hsa05030 | 0.98100058 |
| 53 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.96719375 |
| 54 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.96572194 |
| 55 | Huntingtons disease_Homo sapiens_hsa05016 | 0.94301726 |
| 56 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.94084695 |
| 57 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.93492309 |
| 58 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.93322599 |
| 59 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.92247231 |
| 60 | Melanogenesis_Homo sapiens_hsa04916 | 0.91784050 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91597786 |
| 62 | Insulin resistance_Homo sapiens_hsa04931 | 0.88710828 |
| 63 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.88592672 |
| 64 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.87970908 |
| 65 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.87443837 |
| 66 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.87270300 |
| 67 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.87092724 |
| 68 | Peroxisome_Homo sapiens_hsa04146 | 0.86682002 |
| 69 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.86399567 |
| 70 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.85093803 |
| 71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.84878009 |
| 72 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.82637518 |
| 73 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.82551656 |
| 74 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.82494018 |
| 75 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.82416046 |
| 76 | Alzheimers disease_Homo sapiens_hsa05010 | 0.80096516 |
| 77 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.78119855 |
| 78 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.77808111 |
| 79 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.77093994 |
| 80 | Long-term depression_Homo sapiens_hsa04730 | 0.76486978 |
| 81 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.75607859 |
| 82 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.75509712 |
| 83 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.74808678 |
| 84 | Gap junction_Homo sapiens_hsa04540 | 0.74691042 |
| 85 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.73730469 |
| 86 | ABC transporters_Homo sapiens_hsa02010 | 0.73138814 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72427162 |
| 88 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.72256941 |
| 89 | Axon guidance_Homo sapiens_hsa04360 | 0.71785291 |
| 90 | Carbon metabolism_Homo sapiens_hsa01200 | 0.70773227 |
| 91 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.68890620 |
| 92 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68430843 |
| 93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68217561 |
| 94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.67698271 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.67380049 |
| 96 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.67074524 |
| 97 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66883169 |
| 98 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66866227 |
| 99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.66732948 |
| 100 | Histidine metabolism_Homo sapiens_hsa00340 | 0.65901671 |
| 101 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64773755 |
| 102 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.64211760 |
| 103 | Parkinsons disease_Homo sapiens_hsa05012 | 0.63471544 |
| 104 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.62331789 |
| 105 | Sulfur relay system_Homo sapiens_hsa04122 | 0.59971627 |
| 106 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.59377193 |
| 107 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.59081754 |
| 108 | Glioma_Homo sapiens_hsa05214 | 0.58846491 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57926144 |
| 110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57232635 |
| 111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56303233 |
| 112 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.55062483 |
| 113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54133328 |
| 114 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.52974750 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51927140 |
| 116 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51111065 |
| 117 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.50400014 |
| 118 | Bile secretion_Homo sapiens_hsa04976 | 0.49739251 |
| 119 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49295455 |
| 120 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.48428549 |
| 121 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48002763 |
| 122 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.46982332 |
| 123 | Focal adhesion_Homo sapiens_hsa04510 | 0.46213957 |
| 124 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45693103 |
| 125 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.45667015 |
| 126 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.44557243 |
| 127 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44248505 |
| 128 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.43877780 |
| 129 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43645682 |
| 130 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39930039 |
| 131 | Tight junction_Homo sapiens_hsa04530 | 0.36931003 |

